Intratracheal Administration of Acyl Coenzyme A Acyltransferase-1 Inhibitor K-604 Reduces Pulmonary Inflammation Following Bleomycin-Induced Lung Injury.

MLA

Stevenson, Emily R., et al. “Intratracheal Administration of Acyl Coenzyme A Acyltransferase-1 Inhibitor K-604 Reduces Pulmonary Inflammation Following Bleomycin-Induced Lung Injury.” The Journal of Pharmacology and Experimental Therapeutics, vol. 382, no. 3, Sept. 2022, pp. 356–65. EBSCOhost, https://doi.org/10.1124/jpet.122.001284.

APA

Stevenson, E. R., Wilkinson, M. L., Abramova, E., Guo, C., & Gow, A. J. (2022). Intratracheal Administration of Acyl Coenzyme A Acyltransferase-1 Inhibitor K-604 Reduces Pulmonary Inflammation Following Bleomycin-Induced Lung Injury. The Journal of Pharmacology and Experimental Therapeutics, 382(3), 356–365. https://doi.org/10.1124/jpet.122.001284

Chicago

Stevenson, Emily R, Melissa L Wilkinson, Elena Abramova, Changjiang Guo, and Andrew J Gow. 2022. “Intratracheal Administration of Acyl Coenzyme A Acyltransferase-1 Inhibitor K-604 Reduces Pulmonary Inflammation Following Bleomycin-Induced Lung Injury.” The Journal of Pharmacology and Experimental Therapeutics 382 (3): 356–65. doi:10.1124/jpet.122.001284.